EditForce and Mitsubishi Tanabe Pharma Enter into License Agre... - 05 July 2022 17:00

FUKUOKA, Japan, July 5, 2022 /Kyodo JBN-AsiaNet/ -- EditForce, Inc. (Headquarters: Fukuoka, President and CEO: Takashi Ono; hereinafter "EditForce") has entered into a License Agreement (hereinafter "Agreement") with Mitsubishi Tanabe Pharma Corporation (Headquarters: Osaka, Representative Director...

  Octapharma shares new data at ISTH 2022 in its mission to meet... - 04 July 2022 20:00

LACHEN, Switzerland, July 4, 2022 /PRNewswire-AsiaNet/-- - Octapharma to present new clinical and scientific data from across Octapharma's haematology and critical care portfolios during the ISTH 2022 Congress - Data to be presented in 11 poster presentations and during two Supported Symposia - New da...

  Neuromod Publishes Results of Second Large Scale Clinical Tria... - 30 June 2022 21:00

DUBLIN, June 30, 2022 /PRNewswire-AsiaNet/ -- - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire(R) - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after ...

  New biomarkers unlock potential for more effective treatment o... - 30 June 2022 01:21

MADRID, June 29, 2022 /PRNewswire-AsiaNet/ -- - A new study focused on decoding the genetic chaos found in cancer cells is on the cover of the June issue of the scientific journal Nature. - This work reveals novel biomarkers with the potential to improve the development of precision therap...

  Tarkus, the Colombian phyto-therapeutic laboratory that is con... - 29 June 2022 09:51

BOGOTA, Colombia, June 29, 2022 /PRNewswire-AsiaNet/ -- -- Tarkus Pharma Lab, the first pharmaceutical laboratory located in a Free Trade Zone in Colombia, has become a global industry benchmark, developing raw materials and final products derived from medical cannabis with the highest quality, and exp...

  NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal... - 29 June 2022 01:50

MIAMI and FLORENCE, Italy and NAARDEN, Netherlands June 28, 2022 /PRNewswire-AsiaNet/ - Combines NewAmsterdam's lead clinical program obicetrapib with Menarini's deep cardiovascular disease and regional expertise - Total deal value of over 1 billion euros; including 142.5 million euros upfront payment and committed R&D funding pl...

  Amai Proteins, producer of 100% protein sweetener that reduces... - 28 June 2022 09:24

Palo Alto, Calif., June 28, 2022 /PRNewswire-AsiaNet/ -- Amai Proteins , an Israeli start-up developer of novel designer proteins that answer the needs of consumers and industry, is the Global Winner of the 2022 XTC competition. Extreme Tech Challenge (XTC) is the world's ...

  IFN Neurologic and MetaCell Partner to Launch the IFN Neurolog... - 28 June 2022 09:15

CAMBRIDGE, Mass., and PERTH, Australia, June 28, 2022 /PRNewswire-AsiaNet/ -- Summary The Institute of Functional Neuroscience, a world leading treatment and rehabilitation centre utilising the latest technologies in neuroplasticity research, and MetaCell, an innovative life science software company specialised in cuttin...

  JOYSBIO offers SARS-COV-2 Antigen Rapid Test that detects Omic... - 27 June 2022 17:30

TIANJIN, China, June 27, 2022 /PRNewswire-Asianet/ -- As the SARS-COV-2 Omicron subvariants BA.4 and BA.5 make their way across the EU and the US, Joysbio is able to give people the power to administer a rapid test for themselves at home. The Joysbio Coronavirus Antigen Rapid Test Kit can effectively...

  Abcam: Appointment of Vice President of Investor Relations - 27 June 2022 16:00

CAMBRIDGE, England, June 27, 2022 /PRNewswire-AsiaNet/ -- Abcam [https://corporate.abcam.com/] plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment of Tommy Thomas as Vice President of Investor Relations...